Novartis
NVS
NVS
830 hedge funds and large institutions have $20.6B invested in Novartis in 2014 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 309 increasing their positions, 318 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.17% less ownership
Funds ownership: 9.99% → 9.82% (-0.17%)
3% less repeat investments, than reductions
Existing positions increased: 309 | Existing positions reduced: 318
5% less call options, than puts
Call options by funds: $182M | Put options by funds: $192M
Holders
830
Holding in Top 10
60
Calls
$182M
Puts
$192M
Top Buyers
| 1 | +$71.6M | |
| 2 | +$59.3M | |
| 3 | +$50.9M | |
| 4 |
AG
Aperio Group
Sausalito,
California
|
+$45.8M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$44.9M |
Top Sellers
| 1 | -$230M | |
| 2 | -$143M | |
| 3 | -$101M | |
| 4 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
-$73.8M |
| 5 |
HTC
Haverford Trust Company
Radnor,
Pennsylvania
|
-$70.3M |